CR10014A - Derivados de 3-alquilazetidina sustituidos con heterociclos. - Google Patents
Derivados de 3-alquilazetidina sustituidos con heterociclos.Info
- Publication number
- CR10014A CR10014A CR10014A CR10014A CR10014A CR 10014 A CR10014 A CR 10014A CR 10014 A CR10014 A CR 10014A CR 10014 A CR10014 A CR 10014A CR 10014 A CR10014 A CR 10014A
- Authority
- CR
- Costa Rica
- Prior art keywords
- alquilazetidina
- heterocicles
- derivatives
- substituted
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74018305P | 2005-11-28 | 2005-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR10014A true CR10014A (es) | 2008-07-29 |
Family
ID=37779312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR10014A CR10014A (es) | 2005-11-28 | 2008-05-22 | Derivados de 3-alquilazetidina sustituidos con heterociclos. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1954692A1 (ko) |
| KR (1) | KR20080073721A (ko) |
| AR (1) | AR058199A1 (ko) |
| BR (1) | BRPI0619018A2 (ko) |
| CR (1) | CR10014A (ko) |
| DO (1) | DOP2006000261A (ko) |
| EC (1) | ECSP088477A (ko) |
| IL (1) | IL191586A0 (ko) |
| MA (1) | MA30086B1 (ko) |
| NO (1) | NO20082919L (ko) |
| PE (1) | PE20070647A1 (ko) |
| RU (1) | RU2008126248A (ko) |
| SV (1) | SV2009002917A (ko) |
| TW (1) | TW200804317A (ko) |
| WO (1) | WO2007062193A1 (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906652B2 (en) * | 2005-11-28 | 2011-03-15 | Merck Sharp & Dohme Corp. | Heterocycle-substituted 3-alkyl azetidine derivatives |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2009054923A2 (en) * | 2007-10-24 | 2009-04-30 | Merck & Co., Inc. | Synthesis and crystalline forms of cb-1 antagonist/inverse agonist |
| WO2012031220A2 (en) | 2010-09-03 | 2012-03-08 | University Of Florida Research Foundation, Inc. | Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2805810B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
| FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
| FR2805818B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant |
| UA83230C2 (ru) * | 2003-06-11 | 2008-06-25 | Мерк Энд Ко., Инк. | Замещенные производные 3-алкил- и 3-алкенилазетидинов |
| WO2006119260A2 (en) * | 2005-05-02 | 2006-11-09 | Merck & Co., Inc. | Combination of dipeptidyl peptidase-iv inhibitor and a cannabinoid cb1 receptor antagonist for the treatment of diabetes and obesity |
-
2006
- 2006-11-20 AR ARP060105076A patent/AR058199A1/es unknown
- 2006-11-22 KR KR1020087012880A patent/KR20080073721A/ko not_active Application Discontinuation
- 2006-11-22 BR BRPI0619018A patent/BRPI0619018A2/pt not_active IP Right Cessation
- 2006-11-22 WO PCT/US2006/045328 patent/WO2007062193A1/en active Application Filing
- 2006-11-22 RU RU2008126248/04A patent/RU2008126248A/ru not_active Application Discontinuation
- 2006-11-22 EP EP06838347A patent/EP1954692A1/en not_active Withdrawn
- 2006-11-22 TW TW095143274A patent/TW200804317A/zh unknown
- 2006-11-23 PE PE2006001495A patent/PE20070647A1/es not_active Application Discontinuation
- 2006-11-23 DO DO2006000261A patent/DOP2006000261A/es unknown
-
2008
- 2008-05-20 IL IL191586A patent/IL191586A0/en unknown
- 2008-05-22 CR CR10014A patent/CR10014A/es not_active Application Discontinuation
- 2008-05-27 EC EC2008008477A patent/ECSP088477A/es unknown
- 2008-05-28 SV SV2008002917A patent/SV2009002917A/es not_active Application Discontinuation
- 2008-06-25 MA MA31075A patent/MA30086B1/fr unknown
- 2008-06-27 NO NO20082919A patent/NO20082919L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2006000261A (es) | 2007-07-15 |
| AR058199A1 (es) | 2008-01-23 |
| RU2008126248A (ru) | 2010-01-10 |
| NO20082919L (no) | 2008-08-27 |
| WO2007062193A1 (en) | 2007-05-31 |
| TW200804317A (en) | 2008-01-16 |
| BRPI0619018A2 (pt) | 2016-11-29 |
| KR20080073721A (ko) | 2008-08-11 |
| EP1954692A1 (en) | 2008-08-13 |
| MA30086B1 (fr) | 2008-12-01 |
| PE20070647A1 (es) | 2007-08-11 |
| IL191586A0 (en) | 2008-12-29 |
| ECSP088477A (es) | 2008-06-30 |
| SV2009002917A (es) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR10014A (es) | Derivados de 3-alquilazetidina sustituidos con heterociclos. | |
| CR7432A (es) | Amidas sustituidas activas del receptor de canabinoide-1 | |
| NI201100084A (es) | Antagonistas del receptor de orexina de isonicotinamida. | |
| DK2049529T3 (da) | Substituerede diazepan-orexin-receptor- antagonister | |
| SV2009003417A (es) | Antagonistas piridil piperidina del receptor de orexina | |
| ATE394400T1 (de) | Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
| ATE493412T1 (de) | Spirohydantoin-aryl-cgrp-rezeptorantagonisten | |
| AR036302A1 (es) | Asociacion de un antagonista del receptor cb1 con un producto que activa la neurotransmision dopaminergica en el cerebro, las composiciones farmaceuticas que los contienen, y su utilizacion en el tratamiento de la enfermedad de parkinson | |
| CY1111977T1 (el) | Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
| ATE535514T1 (de) | Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten | |
| CY1113798T1 (el) | Υποκατεστημενες ενωσεις διαζεπανης ως ανταγωνιστες υποδοχεα ορεξινης | |
| CR20130214A (es) | Antagonistas del receptor del cgpr de piperidinona carboxamida azaindano | |
| ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
| UA100974C2 (ru) | Соединения замещенных диазепанов как антагонисты орексиновых рецепторов | |
| CL2008002506A1 (es) | Compuestos derivados de bencimidazol sustituido, procedimiento de preparacion, composicion farmaceutica, util en el tratamiento de enfermedades moduladas con antagonistas del receptor fxr, en particular para el tratamiento de los niveles incrementados de lipidos y/o colesterol, enfermedad aterosclerotica, diabetes, cancer, parkinson, alzheimer. | |
| AR036303A1 (es) | Asociacion de un antagonista del receptor cb1 con un producto que activa la neurotransmision dopaminergica en el cerebro, las composiciones farmaceuticas que los contienen, y su utilizacion para el tratamiento de la enfermedad de parkinson | |
| ATE466853T1 (de) | Cgrp-rezeptorantagonisten | |
| CY1113820T1 (el) | Παραγωγα 4-αλκοξυπυριδαζινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| CY1112227T1 (el) | Πιπεριδινυλαμινο-πυριδαζινες και η χρηση τους ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| SV2011003839A (es) | Agentes antifungicos | |
| NZ747778A (en) | Combination of pure 5-ht6 receptor antagonists with nmda receptor antagonist | |
| MX2017012677A (es) | Uso de derivados de esteres de 1,4-di-n-oxido de quinoxalina para el tratamiento de la giardiasis como agentes anti-giardia-lamblia. | |
| CL2010000998A1 (es) | Compuestos derivados de arilsulfonil pirazolin carboxamidina, antagonistas de 5-ht6; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o profilaxis de enfermedades tales como psicosis, epilepsia, enfermedad de parkinson, migraña y enfermedad de alzheimer. | |
| CL2011000234A1 (es) | Compuestos derivados de ciclohexilamida sustituida, antagonista del receptor del factor de liberación de corticotropina (crf-1); composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento y/o prevencion de trastornos gastrointestinales, depresivos, esquizofrenia, parkinson, inflamacion, obesidad, entre otros. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |